Chira Sergiu, Raduly Lajos, Braicu Cornelia, Jurj Ancuta, Cojocneanu-Petric Roxana, Pop Laura, Pileczki Valentina, Ionescu Calin, Berindan-Neagoe Ioana
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Department of Pathophysiology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.
Exp Ther Med. 2018 Aug;16(2):1241-1249. doi: 10.3892/etm.2018.6324. Epub 2018 Jun 19.
Cancer, and particularly colon cancer, is associated with an increasing number of cases resistant to chemotherapy. One approach to overcome this, and to improve the prognosis and outcome of patients, is the use of adjuvant therapy alongside the standard chemotherapy regiment. In the present study, the effect of deuterium-depleted water (DDW) as a potential modulator of adjuvant therapy on DLD-1 colorectal cancer models was assessed. A number of functionality assays were performed, including MTT, apoptosis and autophagy, and mitochondrial activity and senescence assays, in addition to assessing the capacity to modify the pattern of released miRNA via microarray technology. No significant effect on cell viability was identified, but an increase in mitochondrial activity and a weak pro-apoptotic effect were observed in the treated DLD-1 cells cultured in DDW-prepared medium compared with those grown in standard conditions (SC). Furthermore, the findings revealed the capacity of DDW medium to promote senescence to a higher degree compared with SC. The exosome-released miRNA pattern was significantly modified for the cells maintained in DDW compared with those maintained in SC. These findings suggest that DDW may serve as an adjuvant treatment; however, a better understanding of the underlying molecular mechanism of action will be useful for developing novel and efficient therapeutic strategies, in which the transcriptomic pattern serves an important role.
癌症,尤其是结肠癌,与越来越多对化疗耐药的病例相关。克服这一问题并改善患者预后和结局的一种方法是在标准化疗方案的基础上使用辅助治疗。在本研究中,评估了贫氘水(DDW)作为辅助治疗的潜在调节剂对DLD-1结直肠癌模型的影响。除了通过微阵列技术评估改变释放的miRNA模式的能力外,还进行了许多功能测定,包括MTT、凋亡和自噬以及线粒体活性和衰老测定。未发现对细胞活力有显著影响,但与在标准条件(SC)下培养的细胞相比,在DDW制备的培养基中培养的经处理的DLD-1细胞中线粒体活性增加,并且观察到微弱的促凋亡作用。此外,研究结果显示与SC相比,DDW培养基促进衰老的能力更强。与在SC中培养的细胞相比,在DDW中培养的细胞外泌体释放的miRNA模式发生了显著改变。这些发现表明DDW可能用作辅助治疗;然而,更好地理解其潜在的分子作用机制将有助于开发新的高效治疗策略,其中转录组模式起着重要作用。